Monopar Therapeutics
MNPR
#8577
Rank
โ‚น11.57 B
Marketcap
โ‚น2,193
Share price
8.53%
Change (1 day)
1,224.86%
Change (1 year)

Monopar Therapeutics (MNPR) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น0.51 Billion

According to Monopar Therapeutics's latest financial reports the company has โ‚น0.51 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Monopar Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚น1.08 B-28.16%
2021-12-31โ‚น1.51 B23.46%
2020-12-31โ‚น1.22 B29.9%
2019-12-31โ‚น0.94 B95.51%
2018-12-31โ‚น0.48 B-15.96%
2017-12-31โ‚น0.57 B307.19%
2016-12-31โ‚น0.14 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น23.13 B 4,424.34%๐Ÿ‡บ๐Ÿ‡ธ USA